Literature DB >> 8719750

Fucosidosis with dystonia.

B A Gordon1, K E Gordon, H C Seo, M Yang, R A DiCioccio, J S O'Brien.   

Abstract

Fucosidosis, a progressive neurodegenerative disease, evident in early childhood, is associated with progressive loss of mental and motor function and increasing spasticity and hyperreflexia. We report a Canadian male, with clinical features similar to previously reported fucosidosis patients, however, since age 5 he has exhibited progressive dystonic posturing, initially unilateral, but recently involving both lower limbs. Extensive study of his cultured lymphoblasts demonstrated that alpha-fucosidase activity and immunoreactive alpha-fucosidase protein were absent. He is homozygous for the Q422X mutation, a C to T transition within exon 8 of the alpha-fucosidase gene which results in loss of an EcoR1 restriction enzyme cut site. Even among the 4 other reported fucosidosis families having one or more individuals homozygous for this same (Q422X) mutation there was no previous report of dystonia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719750     DOI: 10.1055/s-2007-979784

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  4 in total

1.  MR brain imaging of fucosidosis type I.

Authors:  P Galluzzi; A Rufa; P Balestri; A Cerase; A Federico
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

2.  Fucosidosis: MRI and MRS findings.

Authors:  Ali Yusuf Oner; Ali Cansu; Sergin Akpek; Ayse Serdaroglu
Journal:  Pediatr Radiol       Date:  2007-08-18

Review 3.  Fucosidosis-Clinical Manifestation, Long-Term Outcomes, and Genetic Profile-Review and Case Series.

Authors:  Karolina M Stepien; Elżbieta Ciara; Aleksandra Jezela-Stanek
Journal:  Genes (Basel)       Date:  2020-11-22       Impact factor: 4.096

4.  Diagnosis and Supportive Management of Fucosidosis: A Case Report.

Authors:  Arpanjeet Kaur; Arshdeep S Dhaliwal; Hillary Raynes; Thomas P Naidich; David M Kaufman
Journal:  Cureus       Date:  2019-11-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.